Planetary Habitat Simulation: Bone Metabolism Studies

NCT02637921 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-03-15

No results posted yet for this study

Summary

Bone losses are well known to occur in response to unloading (in microgravity or during immobilisation) and in patients with chronic obstructive airway disease (COPD). However, it is unknown whether there is an interactive effect between hypoxia and musculoskeletal unloading upon bone and mineral metabolism. Fourteen non-obese men, who are otherwise healthy, will undergo 3x 21-day interventions; normobaric normoxic bed rest (NBR; FiO2=21%), normobaric hypoxic ambulatory confinement (HAMB; FiO2=14%; \~4000 m simulated altitude), and normobaric hypoxic bed rest (HBR; FiO2=14%). The effects of hypoxia and bedrest on bone metabolism and phosphor-calcic homeostasis will be assessed (before and during each intervention, and 14 days after each intervention period) using venous blood sampling, 24hr urine collections, and peripheral quantitative computerized tomography (pQCT).

Conditions

Interventions

OTHER

Hypoxia

21 days confinement in normobaric hypoxic (FiO2 = 14%)

OTHER

Ambulatory

Participants hava a standardized activity level throughout the intervention

OTHER

Normoxia

21 days confinement in normobaric normoxic (FiO2 = 21%) environment

OTHER

Bed Rest

Participants remain on supine bed rest throughout the intervention

OTHER

Standardised nutritional intake

Macronutrient, salt and dietary energy intake will be standardized per kg body weight for each participant

Sponsors & Collaborators

  • Jozef Stefan Institute

    collaborator OTHER
  • DLR German Aerospace Center

    collaborator OTHER
  • KTH Royal Institute of Technology

    collaborator OTHER
  • European Commission

    collaborator OTHER
  • University of Nottingham

    lead OTHER

Principal Investigators

  • Igor Mekjavic, PhD · Jozef Stefan Institute

  • Jörn Rittweger, MD, PhD · German Aerospace Center (DLR)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-11-30
Completion
2015-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02637921 on ClinicalTrials.gov